ERS Genomics signs CRISPR patent deal on industrial applications

16-10-2018

ERS Genomics signs CRISPR patent deal on industrial applications

filograph / iStockphoto.com

ERS Genomics, the company providing access to CRISPR/Cas9 IP owned by Emmanuelle Charpentier, has signed a licensing deal with synthetic biology startup Syngulon.


ERS Genomics, CRISPR, patent, Syngulon, patent licensing, CRISPR/Cas9, Emmanuelle Charpentier

LSIPR